Renal and systemic effects of endothelin-1 in diabetic-hypertensive rats.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 21932990)

Published in Clin Exp Hypertens on September 20, 2011

Authors

Cipy Hofman1, Talma Rosenthal, Joseph Winaver, Irit Rubinstein, Rawi Ramadan, Naftali Stern, Rona Limor, Hoda Awad, Zaid Abassi

Author Affiliations

1: Hypertension Research Unit, Department of Physiology and Pharmacology, Sackler School of Medicine, Tel Aviv University, Israel.

Articles by these authors

25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation (2005) 2.71

The Framingham prediction rule is not valid in a European population of treated hypertensive patients. J Hypertens (2002) 2.03

Haptoglobin: basic and clinical aspects. Antioxid Redox Signal (2010) 1.94

Outcomes with nifedipine GITS or Co-amilozide in hypertensive diabetics and nondiabetics in Intervention as a Goal in Hypertension (INSIGHT). Hypertension (2003) 1.71

Gap junctional remodeling by hypoxia in cultured neonatal rat ventricular myocytes. Cardiovasc Res (2005) 1.70

Characterization of normocalcemic primary hyperparathyroidism. Am J Med (2004) 1.69

Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype. Diabetes (2008) 1.64

The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access. Nephrol Dial Transplant (2005) 1.62

Fluid loss, venous congestion, and worsening renal function in acute decompensated heart failure. Eur J Heart Fail (2013) 1.60

Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction. Hypertension (2005) 1.53

Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trial. Arch Intern Med (2004) 1.51

Absence of peroxisome proliferator-activated receptor-alpha abolishes hypertension and attenuates atherosclerosis in the Tsukuba hypertensive mouse. Hypertension (2007) 1.50

Effect of non-drug interventions on arterial properties determined from 24-h ambulatory blood pressure measurements. Hypertens Res (2011) 1.44

Support for religio-political aggression among teenaged boys in Gaza: part II: neuroendocrinological findings. Aggress Behav (2010) 1.41

Attempted forced titration of blood pressure to <130/85 mm Hg in type 2 diabetic hypertensive patients in clinical practice: the diastolic cost. J Clin Hypertens (Greenwich) (2006) 1.41

PANCREATIC INCIDENTALOMA: DIFFERENTIATING NONFUNCTIONING PANCREATIC NEUROENDOCRINE TUMORS FROM INTRAPANCREATIC ACCESSORY SPLEEN. Endocr Pract (2016) 1.39

Non-functioning pituitary adenomas. Best Pract Res Clin Endocrinol Metab (2009) 1.14

Ghrelin secretion is modulated in a nutrient- and gender-specific manner. Clin Endocrinol (Oxf) (2004) 1.10

Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance. Pharmacol Ther (2004) 1.09

Pulmonary hypertension in hemodialysis patients: an unrecognized threat. Semin Dial (2006) 1.09

Idiopathic intracranial hypertension is associated with lower body adiposity. Ophthalmology (2009) 1.07

Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients. Circ Res (2005) 1.07

Double gene deletion reveals lack of cooperation between claudin 11 and claudin 14 tight junction proteins. Cell Tissue Res (2008) 1.07

Neural traces of stress: cortisol related sustained enhancement of amygdala-hippocampal functional connectivity. Front Hum Neurosci (2013) 1.02

The 5 lipoxygenase system in the vasculature: emerging role in health and disease. Mol Cell Endocrinol (2006) 0.98

Aortocaval fistula in rat: a unique model of volume-overload congestive heart failure and cardiac hypertrophy. J Biomed Biotechnol (2011) 0.98

Estrogen-like activity of licorice root constituents: glabridin and glabrene, in vascular tissues in vitro and in vivo. J Steroid Biochem Mol Biol (2004) 0.98

Acute-on-chronic renal failure in the rat: functional compensation and hypoxia tolerance. Am J Nephrol (2006) 0.97

Hyperimmune gammaglobulin for the treatment of West Nile virus encephalitis. Isr Med Assoc J (2009) 0.96

Hyperhomocysteinemia as a component of syndrome X. Metabolism (2003) 0.95

Hyperglycemia and oxidized-LDL exert a deleterious effect on endothelial progenitor cell migration in type 2 diabetes mellitus. Thromb Res (2010) 0.94

The 1,4,5-inositol trisphosphate pathway is a key component in Fas-mediated hypertrophy in neonatal rat ventricular myocytes. Cardiovasc Res (2005) 0.93

Delayed recovery of renal regional blood flow in diabetic mice subjected to acute ischemic kidney injury. Am J Physiol Renal Physiol (2007) 0.93

Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume-overload heart failure. Circulation (2002) 0.93

Impact of pneumoperitoneum on renal perfusion and excretory function: beneficial effects of nitroglycerine. Surg Endosc (2008) 0.93

Adverse effects of pneumoperitoneum on renal function: involvement of the endothelin and nitric oxide systems. Am J Physiol Regul Integr Comp Physiol (2007) 0.92

Oxidative stress in hypertensive,diabetic, and diabetic hypertensive rats. Am J Hypertens (2003) 0.92

Lipoxygenase-derived metabolites are regulators of peroxisome proliferator-activated receptor gamma-2 expression in human vascular smooth muscle cells. Am J Hypertens (2008) 0.92

Prevalence of hypertension in type 2 diabetes mellitus: impact of the tightening definition of high blood pressure and association with confounding risk factors. J Cardiometab Syndr (2006) 0.92

Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome. Fertil Steril (2009) 0.91

Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus. Am J Physiol Renal Physiol (2009) 0.91

Postnatal ablation of POMC neurons induces an obese phenotype characterized by decreased food intake and enhanced anxiety-like behavior. Mol Endocrinol (2013) 0.90

Induction of cardiac hypertrophy by a controlled reproducible sutureless aortocaval shunt in the mouse. J Invest Surg (2005) 0.90

Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism. Eur J Endocrinol (2010) 0.89

Effect of testosterone replacement therapy on arterial stiffness in older hypogonadal men. Eur J Endocrinol (2009) 0.89

Angiotensin II signaling up-regulates the immediate early transcription factor ATF3 in the left but not the right atrium. Basic Res Cardiol (2010) 0.89

Pyrimethamine increases β-hexosaminidase A activity in patients with Late Onset Tay Sachs. Mol Genet Metab (2010) 0.89

Adipose tissue renin-angiotensin-aldosterone system (RAAS) and progression of insulin resistance. Mol Cell Endocrinol (2012) 0.88

The effects of allicin on weight in fructose-induced hyperinsulinemic, hyperlipidemic, hypertensive rats. Am J Hypertens (2003) 0.88

Angiotensin 1-7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model. Diabetes (2012) 0.88

The biochemical pharmacology of renin inhibitors: implications for translational medicine in hypertension, diabetic nephropathy and heart failure: expectations and reality. Biochem Pharmacol (2009) 0.87

Hyperbaric oxygen treatment improves GFR in rats with ischaemia/reperfusion renal injury: a possible role for the antioxidant/oxidant balance in the ischaemic kidney. Nephrol Dial Transplant (2008) 0.86

Phosphodiesterase-5 inhibition attenuates early renal ischemia-reperfusion-induced acute kidney injury: assessment by quantitative measurement of urinary NGAL and KIM-1. Am J Physiol Renal Physiol (2013) 0.85

Therapeutic actions of allylmercaptocaptopril and captopril in a rat model of metabolic syndrome. Am J Hypertens (2007) 0.85

Restoration of blood flow by using continuous perimuscular infiltration of plasmid DNA encoding subterranean mole rat Spalax ehrenbergi VEGF. Proc Natl Acad Sci U S A (2003) 0.85

Is obesity a brain disease? Neurosci Biobehav Rev (2013) 0.85

Urinary NGAL and KIM-1: biomarkers for assessment of acute ischemic kidney injury following nephron sparing surgery. J Urol (2012) 0.84

Hyperandrogenism is associated with earlier age of onset of idiopathic intracranial hypertension in women. Curr Eye Res (2013) 0.84

Vascular endothelial growth factor (VEGF) fails to improve blood flow and to promote collateralization in a diabetic mouse ischemic hindlimb model. Cardiovasc Diabetol (2003) 0.84

Allylmercaptocaptopril: a new antihypertensive drug. Am J Hypertens (2004) 0.84

Synthesis and evaluation of the antiproliferative activities of derivatives of carboxyalkyl isoflavones linked to N-t-Boc-hexylenediamine. J Med Chem (2007) 0.84

Large A-V fistula: pathophysiological consequences and therapeutic perspectives. Curr Vasc Pharmacol (2003) 0.83

The effects of direct factor Xa inhibitor (Rivaroxaban) on the human osteoblastic cell line SaOS2. Connect Tissue Res (2012) 0.83

Popeye domain containing 1 (Popdc1/Bves) is a caveolae-associated protein involved in ischemia tolerance. PLoS One (2013) 0.83

Involvement of the endothelin and nitric oxide systems in the pathogenesis of renal ischemic damage in an experimental diabetic model. Life Sci (2012) 0.83

Sniffing chronic renal failure in rat model by an array of random networks of single-walled carbon nanotubes. ACS Nano (2009) 0.83

Eplerenone potentiates the antiproteinuric effects of enalapril in experimental nephrotic syndrome. Am J Physiol Renal Physiol (2007) 0.83

The effects of S-allylmercaptocaptopril, the synthetic product of allicin and captopril, on cardiovascular risk factors associated with the metabolic syndrome. Atherosclerosis (2005) 0.83

Effects of chronic rosiglitazone treatment on renal handling of salt and water in rats with volume-overload congestive heart failure. Circ Heart Fail (2011) 0.82

Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation. Metabolism (2010) 0.82

Lenticular oxygen toxicity. Invest Ophthalmol Vis Sci (2003) 0.82

Familial Mediterranean fever, an amyloid thyroid goiter and an enlarged parathyroid gland. Isr Med Assoc J (2012) 0.81

Corin: a new player in the regulation of salt-water balance and blood pressure. Curr Opin Nephrol Hypertens (2013) 0.81

Gold nanoparticle sensors for detecting chronic kidney disease and disease progression. Nanomedicine (Lond) (2012) 0.81

Telmisartan in the treatment of Cohen-Rosenthal Diabetic Hypertensive rats: the benefit of PPAR-gamma agonism. Clin Exp Hypertens (2007) 0.81

Differential regulation of ET(A) and ET(B) in the renal tissue of rats with compensated and decompensated heart failure. J Cardiovasc Pharmacol (2004) 0.81

Elucidation of mechanisms of the reciprocal cross talk between gonadotropin-releasing hormone and prostaglandin receptors. Endocrinology (2010) 0.81

25 hydroxy-vitamin D(3)-1alpha hydroxylase expression and activity in cultured human osteoblasts and their modulation by parathyroid hormone, estrogenic compounds and dihydrotestosterone. J Steroid Biochem Mol Biol (2007) 0.81

A non-calcemic Vitamin D analog modulates both nuclear and putative membranal estrogen receptors in cultured human vascular smooth muscle cells. J Steroid Biochem Mol Biol (2004) 0.80

TVP1022 attenuates cardiac remodeling and kidney dysfunction in experimental volume overload-induced congestive heart failure. Circ Heart Fail (2011) 0.80